Evidence map›Paper›PMID 36119606›Full record

ArticleFrontiers in plant science2022

Alternative splicing of

Loreen Linnenbrügger, Lennart Doering, Hannes Lansing, Kerstin Fischer, Jürgen Eirich, Iris Finkemeier, Antje von Schaewen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in plant science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Fine mapping and candidate gene analysis of qSB12TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2023
    Article
  8. Article
  9. Frontiers in plant science · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Loreen LinnenbrüggerDepartment of Biology, Molecular Physiology of Plants, Institute of Plant Biology and Biotechnology, University of Münster (WWU Münster), Münster, Germany.
Lennart DoeringDepartment of Biology, Molecular Physiology of Plants, Institute of Plant Biology and Biotechnology, University of Münster (WWU Münster), Münster, Germany.
Hannes LansingDepartment of Biology, Molecular Physiology of Plants, Institute of Plant Biology and Biotechnology, University of Münster (WWU Münster), Münster, Germany.
Kerstin FischerDepartment of Biology, Molecular Physiology of Plants, Institute of Plant Biology and Biotechnology, University of Münster (WWU Münster), Münster, Germany.
Jürgen EirichDepartment of Biology, Plant Physiology, Institute of Plant Biology and Biotechnology, University of Münster (WWU Münster), Münster, Germany.
Iris FinkemeierDepartment of Biology, Plant Physiology, Institute of Plant Biology and Biotechnology, University of Münster (WWU Münster), Münster, Germany.
Antje von SchaewenDepartment of Biology, Molecular Physiology of Plants, Institute of Plant Biology and Biotechnology, University of Münster (WWU Münster), Münster, Germany.
University of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucose-6-phosphate dehydrogenase is the rate-limiting enzyme of the oxidative pentose-phosphate pathway (OPPP). The OPPP mainly provides NADPH and sugar-phosphate building blocks for anabolic pathways and is present in all eukaryotes. In plant cells, the irreversible part of the OPPP is found in several compartments. Among the isoforms catalyzing the first OPPP step in Arabidopsis, G6PD1 to G6PD4 target plastids (with G6PD1 being also directed to peroxisomes), whereas G6PD5 and G6PD6 operate in the cytosol. We noticed that alternative splice forms

Indexed as

alternative splicingArabidopsiscytosolic G6PD isoformsendoplasmic reticulummetabolonsNADPH formationoxidative pentose phosphate pathway

Identifiers

PMID36119606
PMCPMC9478949
OpenAlexW4294218970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.